{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:04:21Z","timestamp":1787677461322,"version":"build-2784847793"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T00:00:00Z","timestamp":1397001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"},{"start":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T00:00:00Z","timestamp":1397001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep04618","type":"journal-article","created":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T05:13:40Z","timestamp":1397020420000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Pharmacological targeting of the \u03b2-amyloid precursor protein intracellular domain"],"prefix":"10.1038","volume":"4","author":[{"given":"Caterina","family":"Branca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Sarnico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Ruotolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Lanzillotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo Roberto","family":"Viscomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Benarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Porrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Lorenzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Calz\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Pietro","family":"Imbimbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Ottonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Pizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,9]]},"reference":[{"key":"BFsrep04618_CR1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.molmed.2005.02.009","volume":"11","author":"FM LaFerla","year":"2005","unstructured":"LaFerla, F. M. & Oddo, S. Alzheimer's disease: Abeta, tau and synaptic dysfunction. Trends Mol. Med. 11, 170\u20136 (2005).","journal-title":"Trends Mol. Med."},{"key":"BFsrep04618_CR2","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","volume":"81","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe, D. J. Alzheimer's disease: genes, proteins and therapy. Physiol. Rev. 81, 741\u201366 (2001).","journal-title":"Physiol. Rev."},{"key":"BFsrep04618_CR3","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.cellsig.2011.10.007","volume":"24","author":"C Beckett","year":"2012","unstructured":"Beckett, C., Nalivaeva, N. N., Belyaev, N. D. & Turner, A. J. Nuclear signalling by membrane protein intracellular domains: the AICD enigma. Cell. Signal. 24, 402\u20139 (2012).","journal-title":"Cell. Signal."},{"key":"BFsrep04618_CR4","first-page":"591392","volume":"2012","author":"M Takami","year":"2012","unstructured":"Takami, M. & Funamoto, S. gamma-Secretase-Dependent Proteolysis of Transmembrane Domain of Amyloid Precursor Protein: Successive Tri- and Tetrapeptide Release in Amyloid beta-Protein Production. Int. J. Alzheimers Dis. 2012, 591392 (2012).","journal-title":"Int. J. Alzheimers Dis."},{"key":"BFsrep04618_CR5","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.tips.2010.05.007","volume":"31","author":"H Zettl","year":"2010","unstructured":"Zettl, H., Weggen, S., Schneider, P. & Schneider, G. Exploring the chemical space of gamma-secretase modulators. Trends Pharmacol. Sci. 31, 402\u201310 (2010).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFsrep04618_CR6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/JAD-2011-101065","volume":"25","author":"A Haapasalo","year":"2011","unstructured":"Haapasalo, A. & Kovacs, D. M. The many substrates of presenilin\/gamma-secretase. J. Alzheimers Dis. 25, 3\u201328 (2011).","journal-title":"J. Alzheimers Dis."},{"key":"BFsrep04618_CR7","doi-asserted-by":"crossref","first-page":"41443","DOI":"10.1074\/jbc.M110.141390","volume":"285","author":"ND Belyaev","year":"2010","unstructured":"Belyaev, N. D. et al. The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a beta-secretase-dependent pathway. J. Biol. Chem. 285, 41443\u201354 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFsrep04618_CR8","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1242\/jcs.048090","volume":"122","author":"ZV Goodger","year":"2009","unstructured":"Goodger, Z. V. et al. Nuclear signaling by the APP intracellular domain occurs predominantly through the amyloidogenic processing pathway. J. Cell Sci. 122, 3703\u201314 (2009).","journal-title":"J. Cell Sci."},{"key":"BFsrep04618_CR9","doi-asserted-by":"crossref","first-page":"18367","DOI":"10.1073\/pnas.0907652106","volume":"106","author":"K Ghosal","year":"2009","unstructured":"Ghosal, K. et al. Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain. Proc. Natl. Acad. Sci. U. S. A. 106, 18367\u201372 (2009).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"BFsrep04618_CR10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2174\/156720512799361673","volume":"9","author":"U Konietzko","year":"2012","unstructured":"Konietzko, U. AICD nuclear signaling and its possible contribution to Alzheimer's disease. Curr. Alzheimer Res. 9, 200\u201316 (2012).","journal-title":"Curr. Alzheimer Res."},{"key":"BFsrep04618_CR11","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.phrs.2010.05.002","volume":"62","author":"E Buoso","year":"2010","unstructured":"Buoso, E., Lanni, C., Schettini, G., Govoni, S. & Racchi, M. beta-Amyloid precursor protein metabolism: focus on the functions and degradation of its intracellular domain. Pharmacol. Res. 62, 308\u201317 (2010).","journal-title":"Pharmacol. Res."},{"key":"BFsrep04618_CR12","doi-asserted-by":"crossref","first-page":"40288","DOI":"10.1074\/jbc.C100447200","volume":"276","author":"WT Kimberly","year":"2001","unstructured":"Kimberly, W. T., Zheng, J. B., Guenette, S. Y. & Selkoe, D. J. The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner. J. Biol. Chem. 276, 40288\u201392 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFsrep04618_CR13","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1046\/j.1471-4159.2002.01016.x","volume":"82","author":"A Kinoshita","year":"2002","unstructured":"Kinoshita, A., Whelan, C. M., Smith, C. J., Berezovska, O. & Hyman, B. T. Direct visualization of the gamma secretase-generated carboxyl-terminal domain of the amyloid precursor protein: association with Fe65 and translocation to the nucleus. J. Neurochem. 82, 839\u201347 (2002).","journal-title":"J. Neurochem."},{"key":"BFsrep04618_CR14","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1242\/jcs.01323","volume":"117","author":"RC von Rotz","year":"2004","unstructured":"von Rotz, R. C. et al. The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor. J. Cell Sci. 117, 4435\u201348 (2004).","journal-title":"J. Cell Sci."},{"key":"BFsrep04618_CR15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(02)00809-7","volume":"110","author":"SH Baek","year":"2002","unstructured":"Baek, S. H. et al. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. Cell 110, 55\u201367 (2002).","journal-title":"Cell"},{"key":"BFsrep04618_CR16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1126\/science.1058783","volume":"293","author":"X Cao","year":"2001","unstructured":"Cao, X. & Sudhof, T. C. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293, 115\u201320 (2001).","journal-title":"Science"},{"key":"BFsrep04618_CR17","first-page":"1951","volume":"17","author":"HS Kim","year":"2003","unstructured":"Kim, H. S. et al. C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3beta expression. Faseb J. 17, 1951\u20133 (2003).","journal-title":"Faseb J."},{"key":"BFsrep04618_CR18","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/sj.embor.7400704","volume":"7","author":"SS Hebert","year":"2006","unstructured":"Hebert, S. S. et al. Regulated intramembrane proteolysis of amyloid precursor protein and regulation of expression of putative target genes. EMBO Rep. 7, 739\u201345 (2006).","journal-title":"EMBO Rep."},{"key":"BFsrep04618_CR19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1083\/jcb.200505078","volume":"171","author":"KA Ryan","year":"2005","unstructured":"Ryan, K. A. & Pimplikar, S. W. Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain. J. Cell Biol. 171, 327\u201335 (2005).","journal-title":"J. Cell Biol."},{"key":"BFsrep04618_CR20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/sj.embor.7400309","volume":"6","author":"F Telese","year":"2005","unstructured":"Telese, F. et al. Transcription regulation by the adaptor protein Fe65 and the nucleosome assembly factor SET. EMBO Rep. 6, 77\u201382 (2005).","journal-title":"EMBO Rep."},{"key":"BFsrep04618_CR21","doi-asserted-by":"crossref","first-page":"e11866","DOI":"10.1371\/journal.pone.0011866","volume":"5","author":"K Ghosal","year":"2010","unstructured":"Ghosal, K., Stathopoulos, A. & Pimplikar, S. W. APP intracellular domain impairs adult neurogenesis in transgenic mice by inducing neuroinflammation. PLoS One 5, e11866 (2010).","journal-title":"PLoS One"},{"key":"BFsrep04618_CR22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3233\/JAD-2000-23-408","volume":"2","author":"B Passer","year":"2000","unstructured":"Passer, B. et al. Generation of an apoptotic intracellular peptide by gamma-secretase cleavage of Alzheimer's amyloid beta protein precursor. J. Alzheimers Dis. 2, 289\u2013301 (2000).","journal-title":"J. Alzheimers Dis."},{"key":"BFsrep04618_CR23","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.pneurobio.2008.05.002","volume":"85","author":"T Muller","year":"2008","unstructured":"Muller, T., Meyer, H. E., Egensperger, R. & Marcus, K. The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis and cytoskeletal dynamics-relevance for Alzheimer's disease. Prog. Neurobiol. 85, 393\u2013406 (2008).","journal-title":"Prog. Neurobiol."},{"key":"BFsrep04618_CR24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1471-4159.2011.07475.x","volume":"120 Suppl 1","author":"R Pardossi-Piquard","year":"2012","unstructured":"Pardossi-Piquard, R. & Checler, F. The physiology of the beta-amyloid precursor protein intracellular domain AICD. J. Neurochem. 120 Suppl 1, 109\u201324 (2012).","journal-title":"J. Neurochem."},{"key":"BFsrep04618_CR25","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1476-5381.2008.00097.x","volume":"156","author":"BP Imbimbo","year":"2009","unstructured":"Imbimbo, B. P. et al. CHF5074, a novel gamma-secretase modulator, attenuates brain beta-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease. Br. J. Pharmacol. 156, 982\u201393 (2009).","journal-title":"Br. J. Pharmacol."},{"key":"BFsrep04618_CR26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s12031-010-9482-2","volume":"45","author":"A Lanzillotta","year":"2011","unstructured":"Lanzillotta, A. et al. The gamma-secretase modulator CHF5074 reduces the accumulation of native hyperphosphorylated tau in a transgenic mouse model of Alzheimer's disease. J. Mol. Neurosci. 45, 22\u201331 (2011).","journal-title":"J. Mol. Neurosci."},{"key":"BFsrep04618_CR27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3233\/JAD-2010-1366","volume":"20","author":"BP Imbimbo","year":"2010","unstructured":"Imbimbo, B. P. et al. CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease. J. Alzheimers Dis. 20, 159\u201373 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"BFsrep04618_CR28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2202-14-44","volume":"14","author":"S Sivilia","year":"2013","unstructured":"Sivilia, S. et al. Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice. BMC Neurosci. 14, 44 (2013).","journal-title":"BMC Neurosci."},{"key":"BFsrep04618_CR29","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2174\/13892037113149990144","volume":"10","author":"J Ross","year":"2013","unstructured":"Ross, J. et al. CHF5074 Reduces Biomarkers of Neuroinflammation in Patients with Mild Cognitive Impairment: A 12-Week, Double-Blind, Placebo- Controlled Study. Curr. Alzheimer Res. 10, 742\u201353 (2013).","journal-title":"Curr. Alzheimer Res."},{"key":"BFsrep04618_CR30","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1124\/jpet.107.129007","volume":"323","author":"BP Imbimbo","year":"2007","unstructured":"Imbimbo, B. P. et al. 1-(3\u2032,4\u2032-Dichloro-2-fluoro[1,1\u2032-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity. J. Pharmacol. Exp. Ther. 323, 822\u201330 (2007).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFsrep04618_CR31","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/WAD.0b013e3182622ace","volume":"27","author":"BP Imbimbo","year":"2013","unstructured":"Imbimbo, B. P. et al. Pharmacokinetics and Pharmacodynamics of CHF5074 After Short-term Administration in Healthy Subjects. Alzheimer Dis. Assoc. Disord. 27, 278\u201386 (2013).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"BFsrep04618_CR32","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3233\/JAD-2011-101839","volume":"24","author":"C Balducci","year":"2011","unstructured":"Balducci, C. et al. The gamma-secretase modulator CHF5074 restores memory and hippocampal synaptic plasticity in plaque-free Tg2576 mice. J. Alzheimers Dis. 24, 799\u2013816 (2011).","journal-title":"J. Alzheimers Dis."},{"key":"BFsrep04618_CR33","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/jnc.12136","volume":"124","author":"A Giuliani","year":"2013","unstructured":"Giuliani, A. et al. CHF5074 restores visual memory ability and pre-synaptic cortical acetylcholine release in pre-plaque Tg2576 mice. J. Neurochem. 124, 613\u201320 (2013).","journal-title":"J. Neurochem."},{"key":"BFsrep04618_CR34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1471-4159.2001.00012.x","volume":"76","author":"HF Dovey","year":"2001","unstructured":"Dovey, H. F. et al. Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J. Neurochem. 76, 173\u201381 (2001).","journal-title":"J. Neurochem."},{"key":"BFsrep04618_CR35","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nature07055","volume":"453","author":"TL Kukar","year":"2008","unstructured":"Kukar, T. L. et al. Substrate-targeting gamma-secretase modulators. Nature 453, 925\u20139 (2008).","journal-title":"Nature"},{"key":"BFsrep04618_CR36","doi-asserted-by":"crossref","unstructured":"Golde, T. E., Koo, E. H., Felsenstein, K. M., Osborne, B. A. & Miele, L. gamma-Secretase inhibitors and modulators. Biochim. Biophys. Acta (2013).","DOI":"10.1016\/j.bbamem.2013.06.005"},{"key":"BFsrep04618_CR37","doi-asserted-by":"crossref","first-page":"13042","DOI":"10.1523\/JNEUROSCI.2362-09.2009","volume":"29","author":"M Takami","year":"2009","unstructured":"Takami, M. et al. gamma-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment. J. Neurosci. 29, 13042\u201352 (2009).","journal-title":"J. Neurosci."},{"key":"BFsrep04618_CR38","doi-asserted-by":"crossref","first-page":"28530","DOI":"10.1074\/jbc.M203372200","volume":"277","author":"A Kinoshita","year":"2002","unstructured":"Kinoshita, A., Whelan, C. M., Berezovska, O. & Hyman, B. T. The gamma secretase-generated carboxyl-terminal domain of the amyloid precursor protein induces apoptosis via Tip60 in H4 cells. J Biol Chem 277, 28530\u20136 (2002).","journal-title":"J Biol Chem"},{"key":"BFsrep04618_CR39","doi-asserted-by":"crossref","first-page":"24601","DOI":"10.1074\/jbc.M402248200","volume":"279","author":"X Cao","year":"2004","unstructured":"Cao, X. & Sudhof, T. C. Dissection of amyloid-beta precursor protein-dependent transcriptional transactivation. J. Biol. Chem. 279, 24601\u201311 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFsrep04618_CR40","doi-asserted-by":"crossref","first-page":"e15503","DOI":"10.1371\/journal.pone.0015503","volume":"5","author":"AP Barbagallo","year":"2010","unstructured":"Barbagallo, A. P. et al. Tyr(682) in the intracellular domain of APP regulates amyloidogenic APP processing in vivo. PLoS One 5, e15503 (2010).","journal-title":"PLoS One"},{"key":"BFsrep04618_CR41","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1074\/jbc.M609293200","volume":"282","author":"Z Xie","year":"2007","unstructured":"Xie, Z., Dong, Y., Maeda, U., Xia, W. & Tanzi, R. E. RNA interference silencing of the adaptor molecules ShcC and Fe65 differentially affect amyloid precursor protein processing and Abeta generation. J. Biol. Chem. 282, 4318\u201325 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFsrep04618_CR42","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1073\/pnas.0509695103","volume":"103","author":"V Galvan","year":"2006","unstructured":"Galvan, V. et al. Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664. Proc. Natl. Acad. Sci. U. S. A. 103, 7130\u20135 (2006).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"BFsrep04618_CR43","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3233\/JAD-2010-101332","volume":"22","author":"MP Lichtenstein","year":"2010","unstructured":"Lichtenstein, M. P. et al. Secretase-independent and RhoGTPase\/PAK\/ERK-dependent regulation of cytoskeleton dynamics in astrocytes by NSAIDs and derivatives. J. Alzheimers Dis. 22, 1135\u201355 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"BFsrep04618_CR44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1091\/mbc.e06-04-0283","volume":"18","author":"T Muller","year":"2007","unstructured":"Muller, T. et al. Modulation of gene expression and cytoskeletal dynamics by the amyloid precursor protein intracellular domain (AICD). Mol. Biol. Cell 18, 201\u201310 (2007).","journal-title":"Mol. Biol. Cell"},{"key":"BFsrep04618_CR45","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1073\/pnas.0609521104","volume":"104","author":"H Ma","year":"2007","unstructured":"Ma, H. et al. Involvement of beta-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity. Proc. Natl. Acad. Sci. U. S. A. 104, 8167\u201372 (2007).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"BFsrep04618_CR46","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/embor.2008.222","volume":"10","author":"ND Belyaev","year":"2009","unstructured":"Belyaev, N. D., Nalivaeva, N. N., Makova, N. Z. & Turner, A. J. Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease. EMBO Rep. 10, 94\u2013100 (2009).","journal-title":"EMBO Rep."},{"key":"BFsrep04618_CR47","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-1-60761-744-0_7","volume":"670","author":"SW Pimplikar","year":"2011","unstructured":"Pimplikar, S. W. & Suryanarayana, A. Detection of APP intracellular domain in brain tissue. Methods Mol. Biol. 670, 85\u201391 (2011).","journal-title":"Methods Mol. Biol."},{"key":"BFsrep04618_CR48","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1021\/bi801204g","volume":"48","author":"E Winkler","year":"2009","unstructured":"Winkler, E. et al. Purification, pharmacological modulation and biochemical characterization of interactors of endogenous human gamma-secretase. Biochemistry 48, 1183\u201397 (2009).","journal-title":"Biochemistry"},{"key":"BFsrep04618_CR49","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.vaccine.2009.01.102","volume":"27","author":"I Rubio","year":"2009","unstructured":"Rubio, I. et al. Potent anti-HPV immune responses induced by tandem repeats of the HPV16 L2 (20 -- 38) peptide displayed on bacterial thioredoxin. Vaccine 27, 1949\u201356 (2009).","journal-title":"Vaccine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep04618.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep04618","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep04618.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T03:02:59Z","timestamp":1672974179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep04618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,9]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,17]]}},"alternative-id":["BFsrep04618"],"URL":"https:\/\/doi.org\/10.1038\/srep04618","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718344268.793493984","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,9]]},"assertion":[{"value":"31 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was supported in part by Chiesi Farmaceutici, Parma, Italy. Bruno P. Imbimbo is an employee of Chiesi Farmaceutici. The other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4618"}}